vs

Side-by-side financial comparison of COUSINS PROPERTIES INC (CUZ) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

MADRIGAL PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($321.1M vs $255.0M, roughly 1.3× COUSINS PROPERTIES INC). COUSINS PROPERTIES INC runs the higher net margin — -1.4% vs -18.2%, a 16.9% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 13.2%). COUSINS PROPERTIES INC produced more free cash flow last quarter ($135.0M vs $-133.8M).

Cousins Properties Incorporated is a publicly traded real estate investment trust (REIT) that invests in office buildings in Atlanta, Charlotte, Austin, Phoenix, Tampa, and Chapel Hill, North Carolina. The company has developed notable properties including CNN Center, Omni Coliseum, 191 Peachtree Tower, and Emory Point in Atlanta.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

CUZ vs MDGL — Head-to-Head

Bigger by revenue
MDGL
MDGL
1.3× larger
MDGL
$321.1M
$255.0M
CUZ
Growing faster (revenue YoY)
MDGL
MDGL
+197.6% gap
MDGL
210.8%
13.2%
CUZ
Higher net margin
CUZ
CUZ
16.9% more per $
CUZ
-1.4%
-18.2%
MDGL
More free cash flow
CUZ
CUZ
$268.9M more FCF
CUZ
$135.0M
$-133.8M
MDGL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CUZ
CUZ
MDGL
MDGL
Revenue
$255.0M
$321.1M
Net Profit
$-3.5M
$-58.6M
Gross Margin
67.4%
Operating Margin
67.5%
-18.6%
Net Margin
-1.4%
-18.2%
Revenue YoY
13.2%
210.8%
Net Profit YoY
-125.4%
1.4%
EPS (diluted)
$-0.02
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CUZ
CUZ
MDGL
MDGL
Q4 25
$255.0M
$321.1M
Q3 25
$248.3M
$287.3M
Q2 25
$240.1M
$212.8M
Q1 25
$250.3M
$137.3M
Q4 24
$225.3M
$103.3M
Q3 24
$209.2M
$62.2M
Q2 24
$213.0M
Q1 24
$209.2M
$0
Net Profit
CUZ
CUZ
MDGL
MDGL
Q4 25
$-3.5M
$-58.6M
Q3 25
$8.6M
$-114.2M
Q2 25
$14.5M
$-42.3M
Q1 25
$20.9M
$-73.2M
Q4 24
$13.6M
$-59.4M
Q3 24
$11.2M
$-107.0M
Q2 24
$7.8M
Q1 24
$13.3M
$-147.5M
Gross Margin
CUZ
CUZ
MDGL
MDGL
Q4 25
67.4%
Q3 25
67.8%
Q2 25
69.1%
Q1 25
69.2%
96.7%
Q4 24
67.6%
Q3 24
68.5%
Q2 24
66.8%
Q1 24
66.0%
Operating Margin
CUZ
CUZ
MDGL
MDGL
Q4 25
67.5%
-18.6%
Q3 25
68.1%
-39.7%
Q2 25
69.4%
-22.2%
Q1 25
66.0%
-57.8%
Q4 24
65.8%
-64.8%
Q3 24
67.9%
-187.1%
Q2 24
66.4%
Q1 24
66.3%
Net Margin
CUZ
CUZ
MDGL
MDGL
Q4 25
-1.4%
-18.2%
Q3 25
3.5%
-39.8%
Q2 25
6.0%
-19.9%
Q1 25
8.3%
-53.4%
Q4 24
6.1%
-57.5%
Q3 24
5.4%
-172.0%
Q2 24
3.7%
Q1 24
6.4%
EPS (diluted)
CUZ
CUZ
MDGL
MDGL
Q4 25
$-0.02
$-2.55
Q3 25
$0.05
$-5.08
Q2 25
$0.09
$-1.90
Q1 25
$0.12
$-3.32
Q4 24
$0.09
$-2.50
Q3 24
$0.07
$-4.92
Q2 24
$0.05
Q1 24
$0.09
$-7.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CUZ
CUZ
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$5.7M
$198.7M
Total DebtLower is stronger
$3.3B
$339.9M
Stockholders' EquityBook value
$4.7B
$602.7M
Total Assets
$8.9B
$1.3B
Debt / EquityLower = less leverage
0.71×
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CUZ
CUZ
MDGL
MDGL
Q4 25
$5.7M
$198.7M
Q3 25
$4.7M
$295.7M
Q2 25
$416.8M
$186.2M
Q1 25
$5.3M
$183.6M
Q4 24
$7.3M
$100.0M
Q3 24
$76.1M
$232.7M
Q2 24
$6.0M
Q1 24
$5.5M
$622.5M
Total Debt
CUZ
CUZ
MDGL
MDGL
Q4 25
$3.3B
$339.9M
Q3 25
$3.3B
$339.8M
Q2 25
$3.5B
$118.4M
Q1 25
$3.0B
$118.0M
Q4 24
$3.1B
$117.6M
Q3 24
$2.7B
$117.1M
Q2 24
$2.6B
Q1 24
$2.6B
$116.1M
Stockholders' Equity
CUZ
CUZ
MDGL
MDGL
Q4 25
$4.7B
$602.7M
Q3 25
$4.7B
$625.7M
Q2 25
$4.8B
$696.0M
Q1 25
$4.8B
$710.6M
Q4 24
$4.8B
$754.4M
Q3 24
$4.4B
$777.2M
Q2 24
$4.5B
Q1 24
$4.5B
$850.8M
Total Assets
CUZ
CUZ
MDGL
MDGL
Q4 25
$8.9B
$1.3B
Q3 25
$8.9B
$1.4B
Q2 25
$9.1B
$1.0B
Q1 25
$8.7B
$996.6M
Q4 24
$8.8B
$1.0B
Q3 24
$7.8B
$1.1B
Q2 24
$7.7B
Q1 24
$7.7B
$1.1B
Debt / Equity
CUZ
CUZ
MDGL
MDGL
Q4 25
0.71×
0.56×
Q3 25
0.70×
0.54×
Q2 25
0.73×
0.17×
Q1 25
0.63×
0.17×
Q4 24
0.64×
0.16×
Q3 24
0.60×
0.15×
Q2 24
0.58×
Q1 24
0.57×
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CUZ
CUZ
MDGL
MDGL
Operating Cash FlowLast quarter
$402.3M
$-133.5M
Free Cash FlowOCF − Capex
$135.0M
$-133.8M
FCF MarginFCF / Revenue
53.0%
-41.7%
Capex IntensityCapex / Revenue
104.8%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CUZ
CUZ
MDGL
MDGL
Q4 25
$402.3M
$-133.5M
Q3 25
$120.5M
$79.8M
Q2 25
$122.6M
$-47.1M
Q1 25
$44.8M
$-88.9M
Q4 24
$400.2M
$-104.5M
Q3 24
$117.4M
$-67.0M
Q2 24
$125.5M
Q1 24
$28.3M
$-149.2M
Free Cash Flow
CUZ
CUZ
MDGL
MDGL
Q4 25
$135.0M
$-133.8M
Q3 25
$79.0M
Q2 25
Q1 25
Q4 24
$147.5M
$-104.7M
Q3 24
$-67.8M
Q2 24
Q1 24
$-149.5M
FCF Margin
CUZ
CUZ
MDGL
MDGL
Q4 25
53.0%
-41.7%
Q3 25
27.5%
Q2 25
Q1 25
Q4 24
65.5%
-101.3%
Q3 24
-109.0%
Q2 24
Q1 24
Capex Intensity
CUZ
CUZ
MDGL
MDGL
Q4 25
104.8%
0.1%
Q3 25
0.3%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
112.2%
0.2%
Q3 24
1.3%
Q2 24
Q1 24
Cash Conversion
CUZ
CUZ
MDGL
MDGL
Q4 25
Q3 25
14.03×
Q2 25
8.46×
Q1 25
2.14×
Q4 24
29.35×
Q3 24
10.48×
Q2 24
16.01×
Q1 24
2.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CUZ
CUZ

Rental Properties$253.3M99%
Fee And Other Revenue$1.7M1%
Other$1.2M0%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons